This Startup Just Raised $26 Million To Develop Safer Gene Editing Tools
By targeting RNA rather than DNA, Amber Bio aims to treat multiple genetic diseases with fewer safety risks.
Source: forbes.com
Stay updated with breaking news from Jacob Borrajo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By targeting RNA rather than DNA, Amber Bio aims to treat multiple genetic diseases with fewer safety risks.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!